Imaging, genetics and myosin inhibitors reshape hypertrophic cardiomyopathy care
A new review in Cardiovascular Ultrasound synthesizes how advanced imaging, genetic testing and cardiac myosin inhibitors are transforming the diagnosis ...
A new review in Cardiovascular Ultrasound synthesizes how advanced imaging, genetic testing and cardiac myosin inhibitors are transforming the diagnosis ...
A Frontiers in Oncology case report documents a 62-year-old woman carrying the known pathogenic MSH2 p.A230Lfs*16 germline variant who developed ...
Whole-exome sequencing of 568 cardiomyopathy patients found pathogenic variants in nearly three-quarters of those with restrictive filling physiology, with MYBPC3, ...
A case report describes two Chinese women with severe Danon disease initially suspected of cardiac amyloidosis, diagnosed through biopsy and ...
A retrospective Japanese cohort study associated expanded insurance coverage for BRCA testing with a median testing interval of 54 days ...
A qualitative study of 15 Peruvians found that hereditary cancer testing and diagnosis were shaped by faith, family networks, community ...
A cross-sectional study found that 36.16% of at-risk relatives underwent family-specific genetic testing, with uptake independently associated with education, family ...
A 2026 single-patient case report identifies a previously unreported p.Y76C variant in ELOC (TCEB1)-mutant renal cell carcinoma in a 52-year-old ...
A nucleotide-resolved analysis of ClinVar and gnomAD reveals seventeen epilepsy variants dramatically enriched in East Asian populations and shows the ...
A 13-year analysis of 3.68 million ClinVar variants found that only 0.68 percent ever crossed the clinically actionable boundary between ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine